Highlights of Prescribing Information: Wegovy (semaglutide) injection, for subcutaneous use Wegovy (semaglutide) tablets, for oral use
Metabolic and Weight-Regulation Peptides The metabolic peptide class has undergone a revolution over the past five years, largely driven by research on GLP-1 receptor agonists
You may consider stopping or taking a break after several months, once you achieve your desired results, or if you experience side effects
The active receptor targets are the same, but the formulation, source, and regulatory pathway differ
Preserving lean muscle during weight loss is essential for maintaining metabolic health
Supporting muscle health while on GLP-1 medications Preventing muscle loss while using Ozempic and other GLP-1 medications involves a multifaceted approach that prioritizes nutrition, exercise, and supplementation